TITLE:
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients

CONDITION:
Anemia

INTERVENTION:
Epoetin alfa or beta

SUMMARY:

      This study will assess the efficacy and safety of intravenous Mircera, given as maintenance
      treatment for renal anemia in chronic kidney disease patients on dialysis who were
      previously receiving iv epoetin. The anticipated time on study treatment is 1-2 years and
      the target sample size is 100-500 individuals.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  adult patients >=18 years of age;

          -  chronic renal anemia;

          -  on dialysis therapy for at least 12 weeks before screening;

          -  receiving IV epoetin for at least 8 weeks before screening.

        Exclusion Criteria:

          -  women who are pregnant, breastfeeding or using unreliable birth control methods;

          -  administration of another investigational drug within 4 weeks before screening, or
             during the study period.
      
